A detailed history of Jane Street Group, LLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Jane Street Group, LLC holds 726,017 shares of ME stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
726,017
Previous 2,287,695 68.26%
Holding current value
$2.22 Million
Previous $892,000 71.52%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.29 - $0.51 $452,886 - $796,455
-1,561,678 Reduced 68.26%
726,017 $254,000
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.61 $568,886 - $963,946
1,580,240 Added 223.37%
2,287,695 $892,000
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $112,784 - $256,583
281,960 Added 66.27%
707,455 $374,000
Q4 2023

Feb 14, 2024

BUY
$0.71 - $0.97 $292,187 - $399,186
411,532 Added 2947.3%
425,495 $387,000
Q3 2023

Nov 14, 2023

SELL
$0.96 - $2.01 $69,739 - $146,016
-72,645 Reduced 83.88%
13,963 $13,000
Q2 2023

Aug 14, 2023

BUY
$1.59 - $2.29 $41,702 - $60,062
26,228 Added 43.44%
86,608 $151,000
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $123,778 - $173,290
60,380 New
60,380 $137,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $12,854 - $25,313
4,944 Added 40.58%
17,128 $49,000
Q2 2022

Aug 16, 2022

SELL
$2.19 - $3.98 $497,381 - $903,917
-227,115 Reduced 94.91%
12,184 $30,000
Q1 2022

May 17, 2022

SELL
$3.28 - $7.12 $897,962 - $1.95 Million
-273,769 Reduced 53.36%
239,299 $916,000
Q4 2021

Feb 15, 2022

BUY
$6.55 - $13.25 $2.62 Million - $5.31 Million
400,618 Added 356.26%
513,068 $3.42 Million
Q2 2021

Aug 16, 2021

BUY
$9.87 - $13.32 $1.11 Million - $1.5 Million
112,450 New
112,450 $1.31 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $795M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.